Interferon-α-2b Nasal Spray for Treating SARS-CoV-2 Omicron Variant-Infected Children
J Clin Immunol
.
2023 Jul;43(5):862-864.
doi: 10.1007/s10875-023-01452-4.
Epub 2023 Feb 21.
Authors
Jianguo Zhou
1
,
Xiang Chen
1
,
Yanming Lu
2
,
Libo Wang
3
,
Hui Yu
4
Affiliations
1
Department of Neonatology, Children's Hospital of Fudan University, Shanghai, China.
2
Department of Pediatrics, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.
3
Department of Respiratory Disease, Children's Hospital of Fudan University, Shanghai, China.
4
Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, China. yuhui4756@sina.com.
PMID:
36809596
PMCID:
PMC9942035
DOI:
10.1007/s10875-023-01452-4
No abstract available
Keywords:
Children; Interferon-α-2b; Nasal spray; SARS-CoV-2 Omicron variant.
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Child
Humans
Nasal Sprays
SARS-CoV-2
Substances
Nasal Sprays
Supplementary concepts
SARS-CoV-2 variants